Efficacy and safety of 0.15 % isobutylamido thiazolyl resorcinol combined with hyaluronic acid versus 0.15 % isobutylamido thiazolyl resorcinol or hyaluronic acid alone in melasma treatment: A randomized evaluator‐blind trial

Author(s):  
Wareeporn Disphanurat ◽  
Benjaporn Srisantithum
2011 ◽  
Vol 5 (S1) ◽  
pp. 269-270
Author(s):  
T. Dietrich ◽  
R. Leeson ◽  
B. Zielińska-Kaźmierska ◽  
M. Opadczuk ◽  
E. Kozieł ◽  
...  

1997 ◽  
Vol 171 (1) ◽  
pp. 73-77 ◽  
Author(s):  
I. Pelc ◽  
P. Verbanck ◽  
O. Le Bon ◽  
M. Gavrilovic ◽  
K. Lion ◽  
...  

BackgroundAcamprosate is a newly registered drug that appears to reduce alcohol-drinking in both animal models and clinical conditions.MethodIn order to assess the efficacy and safety of the drug in the treatment of detoxified alcoholics, we performed a 90-day double-blind trial comparing two dosages of acamprosate (1332 mg/day and 1998 mg/day).ResultsFor all efficacy parameters, acamprosate appeared to be significantly superior to placebo, with a trend towards a better effect at the higher dosage. Furthermore, acamprosate appeared to be extremely safe.ConclusionThis study confirms that acamprosate could be an interesting adjuvant for maintaining abstinence in detoxified alcoholics.


2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Lieschen H. Quiroz ◽  
Domingo E Galliano ◽  
Giovanna da Silva ◽  
Joseph C. Carmichael ◽  
Li-Chen Pan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document